{"product_id":"selank-ac-selank-nh2-5-10mg-pen","title":"Selank (AC-Selank-NH2) | 15 Mg Pen","description":"\u003cp\u003eSelank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the endogenous immunomodulatory peptide tuftsin and explored as a regulatory neuropeptide in stress-response and cognitive-stability research. Across clinical, preclinical, and in vitro work, it has been studied for its relationship to GABAergic tone, monoaminergic signaling context, and neuroimmune marker patterns under stress-relevant conditions. Information on this page is provided for scientific and educational context only and does not represent medical guidance or therapeutic claims.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSupports\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eStress-response signaling context tracked through inhibitory neurotransmission (GABA-related) readouts in models.\u003c\/li\u003e\n\u003cli\u003eMonoaminergic balance frameworks associated with serotonin\/dopamine signaling markers.\u003c\/li\u003e\n\u003cli\u003eCognitive stability endpoints monitored under stress-exposure paradigms.\u003c\/li\u003e\n\u003cli\u003eNeuroimmune interaction context assessed via cytokine and inflammation-related gene-expression patterns.\u003c\/li\u003e\n\u003cli\u003eNeurotrophic and synaptic-function research readouts in controlled experimental systems.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eSelank\u003c\/strong\u003e is a tuftsin-derived synthetic heptapeptide developed within the broader class of glyproline regulatory peptides. It is widely referenced in neurobehavioral research because its reported profile differs from classical sedative anxiolytics: rather than acting as a direct GABA-A receptor agonist, Selank is commonly described as a modulator of inhibitory signaling tone and broader neurotransmission-related pathways in model systems.\u003c\/p\u003e\n\u003cp\u003eIn controlled research settings, Selank has been evaluated in stress-exposure paradigms and cognitive-performance contexts where behavioral endpoints are paired with molecular readouts (e.g., neurotransmission-related gene expression, cytokine markers, and neurotrophic-factor signaling context). Reported observations are model- and protocol-dependent and should be interpreted within each study’s design and endpoints.\u003c\/p\u003e\n\u003cp\u003eSelank is presented here for controlled research and educational context only. It is not marketed as an approved therapeutic product, and outcomes can vary substantially by model, endpoints, and study design.\u003c\/p\u003e\n\u003ch2\u003eClinical Status\u003c\/h2\u003e\n\u003cp\u003eSelank has published human research in anxiety-related study contexts as well as extensive preclinical and in vitro investigation of neurotransmission and neuroimmune endpoints. It is not presented here as an approved therapeutic product, and interpretation should remain study-specific and endpoint-driven.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEvidence type:\u003c\/strong\u003e\u003cbr\u003eHuman RCT ✔ | Observational ☐ | Animal ✔ | In vitro ✔ | Regulatory approval ☐\u003c\/p\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eMechanistic narratives around Selank commonly emphasize modulation of inhibitory neurotransmission and downstream stress-response signaling. Transcriptomic and molecular studies report changes in gene-expression patterns related to neurotransmission, with particular focus on GABAergic system context and its intersection with stress-related pathways. Experimental work also discusses monoaminergic signaling markers (serotonin\/dopamine context) as part of broader regulation of emotional and cognitive stability readouts.\u003c\/p\u003e\n\u003cp\u003eBeyond neurotransmission, Selank has been investigated for neuroimmune interactions, including cytokine-related readouts and inflammation-associated gene expression under stress conditions. Some electrophysiology studies also explore effects on inhibitory synaptic transmission in hippocampal systems, positioning Selank within synaptic-function research frameworks.\u003c\/p\u003e\n\u003ch2\u003eBenefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eModulation Of GABAergic Signaling:\u003c\/b\u003e\u003cbr\u003eSelank has been studied for its ability to influence GABA turnover without directly binding to GABA-A receptors. Research indicates normalization of inhibitory neurotransmission in stress-exposed animal models. Unlike benzodiazepines, Selank does not produce strong sedative or motor-impairing effects in experimental settings. Behavioral studies demonstrate reduced anxiety markers with preserved cognitive function. Evidence type: Human clinical studies ✔ | Animal ▣.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSerotonin And Dopamine Regulation:\u003c\/b\u003e\u003cbr\u003ePreclinical and clinical data suggest modulation of monoamine systems, particularly serotonin and dopamine pathways. Research indicates improved neurotransmitter balance under stress conditions. Laboratory findings demonstrate altered transporter expression and receptor sensitivity. These mechanisms contribute to emotional stability and cognitive clarity research contexts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAnxiety Model Performance Improvements:\u003c\/b\u003e\u003cbr\u003eClinical studies in anxiety-related research populations demonstrate measurable reductions in anxiety scoring scales. Behavioral assessments show improved emotional regulation without cognitive dulling. Comparative studies suggest preservation of attentional performance during administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStress-Response Regulation:\u003c\/b\u003e\u003cbr\u003eAnimal models indicate ↓ stress-induced corticosterone elevation following Selank exposure. Research suggests modulation of hypothalamic-pituitary-adrenal axis signaling. These effects contribute to stabilized physiological stress responses in experimental settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNeuroimmune Interaction Modulation:\u003c\/b\u003e\u003cbr\u003eGene expression studies demonstrate influence on inflammatory cytokine regulation within neural tissue. Research indicates potential interplay between immune signaling and neural modulation pathways. This dual regulatory profile distinguishes Selank from purely neurotransmitter-targeted compounds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCognitive Stability Under Stress Conditions:\u003c\/b\u003e\u003cbr\u003eSelank has been evaluated in cognitive testing models under acute stress exposure. Research demonstrates preservation of memory recall and executive performance compared to controls. Mechanistic hypotheses involve monoaminergic stabilization and reduced stress hormone signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNon-Sedative Regulatory Profile:\u003c\/b\u003e\u003cbr\u003eUnlike classical anxiolytic agents, Selank does not produce significant sedation in controlled research models. Motor coordination and reaction time metrics remain largely preserved. This characteristic supports its positioning in cognitive-focused anxiety research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eHigh Bioavailability Through Subcutaneous Administration:\u003c\/b\u003e\u003cbr\u003eProvided in a stabilized pre-mixed injection pen for SubQ administration, ensuring consistent systemic exposure in research protocols. Subcutaneous delivery supports reliable absorption and simplified laboratory handling. Each unit is freshly prepared and intended strictly for research use only.\u003c\/li\u003e\n\u003cli\u003e\u003cbr\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eResearch Data\u003c\/h2\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"10\" style=\"width: 100%;\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eStudy\/model\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported effect\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eHuman clinical study context (generalized anxiety \/ neurasthenia)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported improvements in psychometric scale readouts compared with an active comparator in a controlled clinical setting (study-specific outcomes).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eNeurotransmission gene-expression profiling (rodent brain; transcriptomic)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported alterations in expression of genes involved in neurotransmission, discussed alongside GABAergic system context and regulatory signaling hypotheses.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eGABA\/Selank comparative expression studies\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported overlaps and differences in gene-expression responses following Selank and GABA exposure in controlled model systems.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eCytokine readouts under social stress (animal)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported changes in cytokine-level patterns under stress exposure, framed as stress-protective activity signals in an animal model.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eInflammation-related gene expression (mouse spleen)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported alterations in inflammation-related gene-expression markers following Selank exposure (endpoint-dependent).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eElectrophysiology (hippocampal inhibitory synaptic transmission)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported changes in inhibitory synaptic transmission readouts in CA1 pyramidal-cell recordings in controlled experiments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 37.8136%;\"\u003eStress models with comparator (diazepam; animal)\u003c\/td\u003e\n\u003ctd style=\"width: 62.1864%;\"\u003eReported anxiety-related behavioral readout changes with Selank alone and in combination with a comparator under chronic mild stress conditions.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eStack Suggestions\u003c\/h2\u003e\n\u003cp\u003eIn extended experimental designs, Selank is sometimes paired with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSemax (neurotrophic and cognitive-endpoint frameworks, where applicable)\u003c\/li\u003e\n\u003cli\u003eDSIP (sleep\/stress-endpoint study designs, depending on protocol)\u003c\/li\u003e\n\u003cli\u003eNAD+ (bioenergetic and stress-resilience marker panels in broader neurobiology studies)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStacks discussed are for experimental design only, not safety\/efficacy guidance.\u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp\u003eIn research contexts, tolerability notes for Selank are generally described as mild and model-dependent. Where administered, observations may include transient local sensitivity or short-lived systemic effects. These notes are provided for general context only; they do not constitute medical guidance.\u003c\/p\u003e\n\u003cp\u003eInjection-site sensitivity: Temporary redness, swelling, or discomfort has been reported in some settings.\u003cbr\u003eHeadache or fatigue: Transient effects have been noted anecdotally in certain protocols.\u003cbr\u003eDizziness or nausea: Occasional reports during early exposure windows in some settings.\u003cbr\u003eSensitivity reactions: Rare hypersensitivity-like responses are possible and warrant caution.\u003c\/p\u003e\n\u003ch2\u003eScientific References\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18454096\/\"\u003eEfficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia\u003c\/a\u003e — Human clinical study\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30255741\/\"\u003eThe Molecular Aspects of Heptapeptide Selank Biological Activity\u003c\/a\u003e — Review\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26924987\/\"\u003eSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission\u003c\/a\u003e — Animal \/ gene expression\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4757669\/\"\u003eSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission (full text)\u003c\/a\u003e — Animal \/ gene expression (PMC)\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2017.00089\/full\"\u003eGABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission\u003c\/a\u003e — Transcriptomic \/ mechanistic context\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32621722\/\"\u003eThe Influence of Selank on the Level of Cytokines Under Social Stress Conditions\u003c\/a\u003e — Animal \/ cytokines\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28280289\/\"\u003ePeptide Selank Enhances the Effect of Diazepam in Unpredictable Chronic Mild Stress Conditions\u003c\/a\u003e — Animal \/ stress model\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2017\/5091027\"\u003ePeptide Selank Enhances the Effect of Diazepam in Unpredictable Chronic Mild Stress Conditions (full article page)\u003c\/a\u003e — Animal \/ stress model\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22390072\/\"\u003ePeptidergic modulation of the hippocampus synaptic activity\u003c\/a\u003e — Electrophysiology (inhibitory synaptic transmission)\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0167011511000863\"\u003eExpression of inflammation-related genes in mouse spleen after administration of Selank and its fragments\u003c\/a\u003e — Animal \/ gene expression\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eFor educational and scientific context only; not intended to diagnose, treat, cure, or prevent any disease.\u003c\/li\u003e\n\u003cli\u003eIf you are pregnant, nursing, have a medical condition, or use prescription medication, consult a qualified professional.\u003c\/li\u003e\n\u003cli\u003eDiscontinue use if sensitivity occurs.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Peptoora","offers":[{"title":"Default Title","offer_id":61559768580426,"sku":"PE-NT-PEN-002","price":349.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0887\/1139\/7706\/files\/AC-Selank-NH210mg.png?v=1775795456","url":"https:\/\/peptoora.com\/es\/products\/selank-ac-selank-nh2-5-10mg-pen","provider":"Peptoora LTD","version":"1.0","type":"link"}